Caxton Associates LP Buys 112,656 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV)

Caxton Associates LP boosted its position in Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) by 954.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 124,460 shares of the company's stock after buying an additional 112,656 shares during the quarter. Caxton Associates LP's holdings in Clover Health Investments were worth $392,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Marshall Wace LLP increased its position in Clover Health Investments by 167.6% during the 4th quarter. Marshall Wace LLP now owns 3,769,765 shares of the company's stock worth $11,875,000 after buying an additional 2,360,902 shares during the period. Teacher Retirement System of Texas acquired a new stake in Clover Health Investments during the 4th quarter valued at approximately $2,769,000. Schonfeld Strategic Advisors LLC purchased a new position in Clover Health Investments in the fourth quarter valued at $1,860,000. American Century Companies Inc. boosted its position in Clover Health Investments by 181.0% during the fourth quarter. American Century Companies Inc. now owns 764,694 shares of the company's stock worth $2,409,000 after acquiring an additional 492,527 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Clover Health Investments by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company's stock worth $61,693,000 after acquiring an additional 386,499 shares during the last quarter. 19.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group upped their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a "buy" rating in a research note on Monday, March 3rd.

Insider Buying and Selling at Clover Health Investments

In other news, CEO Brady Patrick Priest sold 75,000 shares of Clover Health Investments stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $3.68, for a total transaction of $276,000.00. Following the sale, the chief executive officer now directly owns 2,418,151 shares in the company, valued at $8,898,795.68. The trade was a 3.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Carladenise Armbrister Edwards sold 200,000 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $3.61, for a total transaction of $722,000.00. Following the completion of the sale, the director now directly owns 273,227 shares in the company, valued at $986,349.47. This represents a 42.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 327,500 shares of company stock worth $1,197,500 over the last 90 days. Insiders own 22.28% of the company's stock.

Clover Health Investments Stock Performance

Shares of NASDAQ:CLOV traded down $0.04 during trading hours on Tuesday, reaching $3.43. The stock had a trading volume of 4,174,730 shares, compared to its average volume of 6,793,597. Clover Health Investments, Corp. has a 1 year low of $0.82 and a 1 year high of $4.87. The firm's 50 day moving average is $3.56 and its 200-day moving average is $3.71. The stock has a market capitalization of $1.75 billion, a price-to-earnings ratio of -17.15 and a beta of 1.99.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.12. The firm had revenue of $462.33 million for the quarter, compared to the consensus estimate of $466.93 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. Analysts forecast that Clover Health Investments, Corp. will post -0.12 EPS for the current year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.